###begin article-title 0
Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus
###end article-title 0
###begin p 1
###xml 620 621 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 821 824 821 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">off</sub>
###xml 836 838 836 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 840 842 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 859 861 859 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 863 865 863 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 62 73 <span type="species:ncbi:121791">Nipah virus</span>
###xml 75 78 <span type="species:ncbi:121791">NiV</span>
###xml 336 339 <span type="species:ncbi:121791">NiV</span>
###xml 503 506 <span type="species:ncbi:121791">NiV</span>
###xml 529 532 <span type="species:ncbi:121791">NiV</span>
###xml 545 548 <span type="species:ncbi:121791">NiV</span>
###xml 763 766 <span type="species:ncbi:121791">NiV</span>
###xml 979 982 <span type="species:ncbi:121791">NiV</span>
###xml 1033 1036 <span type="species:ncbi:121791">NiV</span>
###xml 1126 1129 <span type="species:ncbi:121791">NiV</span>
###xml 1330 1333 <span type="species:ncbi:121791">NiV</span>
###xml 1460 1463 <span type="species:ncbi:121791">NiV</span>
###xml 1548 1551 <span type="species:ncbi:121791">NiV</span>
###xml 1651 1654 <span type="species:ncbi:121791">NiV</span>
EphrinB2 was recently discovered as a functional receptor for Nipah virus (NiV), a lethal emerging paramyxovirus. Ephrins constitute a class of homologous ligands for the Eph class of receptor tyrosine kinases and exhibit overlapping expression patterns. Thus, we examined whether other ephrins might serve as alternative receptors for NiV. Here, we show that of all known ephrins (ephrinA1-A5 and ephrinB1-B3), only the soluble Fc-fusion proteins of ephrinB3, in addition to ephrinB2, bound to soluble NiV attachment protein G (NiV-G). Soluble NiV-G bound to cell surface ephrinB3 and B2 with subnanomolar affinities (Kd = 0.58 nM and 0.06 nM for ephrinB3 and B2, respectively). Surface plasmon resonance analysis indicated that the relatively lower affinity of NiV-G for ephrinB3 was largely due to a faster off-rate (Koff = 1.94 x 10-3 s-1 versus 1.06 x 10-4 s-1 for ephrinB3 and B2, respectively). EphrinB3 was sufficient to allow for viral entry of both pseudotype and live NiV. Soluble ephrinB2 and B3 were able to compete for NiV-envelope-mediated viral entry on both ephrinB2- and B3-expressing cells, suggesting that NiV-G interacts with both ephrinB2 and B3 via an overlapping site. Mutational analysis indicated that the Leu-Trp residues in the solvent exposed G-H loop of ephrinB2 and B3 were critical determinants of NiV binding and entry. Indeed, replacement of the Tyr-Met residues in the homologous positions in ephrinB1 with Leu-Trp conferred NiV receptor activity to ephrinB1. Thus, ephrinB3 is a bona fide alternate receptor for NiV entry, and two residues in the G-H loop of the ephrin B-class ligands are critical determinants of NiV receptor activity.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 131 142 <span type="species:ncbi:121791">Nipah virus</span>
###xml 386 397 <span type="species:ncbi:121791">Nipah virus</span>
###xml 638 649 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus is a deadly virus that can cause death in up to 70% of infected patients, mostly from fatal inflammation of the brain. Nipah virus is considered a "priority pathogen" for bioterrorism purposes, and it has the potential for widespread economic devastation as it can spread rapidly among susceptible livestock. The authors had previously identified the receptor that mediates Nipah virus entry into cells. This receptor, ephrinB2, is a critical molecule for the development of the vascular and nervous system and is highly expressed on endothelial cells and neurons, which are also the two cell types preferentially infected by Nipah virus in vivo.
###end p 3
###begin p 4
###xml 253 264 <span type="species:ncbi:121791">Nipah virus</span>
###xml 542 545 <span type="species:ncbi:121791">NiV</span>
###xml 611 614 <span type="species:ncbi:121791">NiV</span>
EphrinB2 belongs to a large family of related molecules that are variably conserved in structure and function. Thus, the authors screened all known ephrins, and found that a closely related molecule, ephrinB3, also can function as an entry receptor for Nipah virus. In addition, the authors established that while ephrinB2 was better used than ephrinB3 as an entry receptor, the same two critical amino acids in ephrinB2 and B3 were responsible for the viral receptor activity of these molecules. The discovery of a more comprehensive set of NiV receptors will aid our understanding of the pathology underlying NiV disease.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 79 90 79 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Henipavirus</italic>
###xml 111 126 111 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paramyxoviridae</italic>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b001">1</xref>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b002">2</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b003">3</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b004">4</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b005">5</xref>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b006">6</xref>
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
###xml 13 16 <span type="species:ncbi:121791">NiV</span>
###xml 134 137 <span type="species:ncbi:121791">NiV</span>
###xml 307 310 <span type="species:ncbi:121791">NiV</span>
###xml 320 324 <span type="species:ncbi:9823">pigs</span>
###xml 365 368 <span type="species:ncbi:121791">NiV</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 550 553 <span type="species:ncbi:121791">NiV</span>
###xml 633 636 <span type="species:ncbi:121791">NiV</span>
###xml 691 697 <span type="species:ncbi:9606">humans</span>
###xml 766 769 <span type="species:ncbi:9823">pig</span>
Nipah virus (NiV) is a zoonotic paramyxovirus classified in the taxonomic unit Henipavirus under the family of Paramyxoviridae [1,2]. NiV emerged in peninsular Malaysia and Singapore in 1998-1999 when cases of severe acute encephalitis occurred among agricultural and abattoir workers in close contact with NiV-infected pigs [3]. In 2004 two confirmed outbreaks of NiV in Bangladesh recorded mortality rates of greater than 70% with evidence of human-to-human transmission [4,5]. Due to high mortality rates and its potential use as a bioweapon [6], NiV has been classified as a Category C priority pathogen for biodefense purposes. NiV not only has the potential to cause severe disease in humans, but also represents a critical economic threat if used against the pig-farming industry.
###end p 6
###begin p 7
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b007">7</xref>
###xml 535 536 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b008">8</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b009">9</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b010">10</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b011">11</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b007">7</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b012">12</xref>
###xml 31 34 <span type="species:ncbi:121791">NiV</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 98 101 <span type="species:ncbi:121791">NiV</span>
###xml 381 384 <span type="species:ncbi:121791">NiV</span>
###xml 514 517 <span type="species:ncbi:121791">NiV</span>
###xml 642 645 <span type="species:ncbi:121791">NiV</span>
Pathological investigations of NiV-infected patients revealed that a major cellular target of the NiV appears to be endothelial cells that line blood vessels [7]. More important, syncytial or multinucleated giant endothelial cells were seen in the microvasculature of many organs, with the most severe damage occurring to vessels in the central nervous system (CNS). Concordantly, NiV antigen load was highest in the brain parenchyma, especially in neurons, compared with other organs. The functional receptor for NiV entry, ephrinB2 [8,9], is expressed on endothelial cells and neurons [10,11] consistent with the known cellular tropism for NiV [7,12].
###end p 7
###begin p 8
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b013">13</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b011">11</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b013">13</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b015">15</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b016">16</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b017">17</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b018">18</xref>
Ephrins are the highly conserved ligands to the Eph family of receptor tyrosine kinases [13]. Eph-ephrin signaling functions in both embryonic and adult tissues by regulating processes such as angiogenesis, neuron axonal guidance, and tumorgenesis [11,13-15]. Both ephrins and Eph receptors are categorized into class-A and class-B proteins based on sequence homology, binding affinities, and the manner of ephrin membrane attachment. In general, ephrin ligands and receptors can interact promiscuously inside their own class but not outside of it. An exception to the rule is the binding of EphA4 to ephrinB3, an interaction thought to be important in corticospinal neurons crossing the spinal cord midline [16,17]. Ephrins have extremely conserved features, especially within a class, and can have overlapping but distinct expression patterns [18].
###end p 8
###begin p 9
###xml 30 33 <span type="species:ncbi:121791">NiV</span>
###xml 56 59 <span type="species:ncbi:121791">NiV</span>
###xml 203 206 <span type="species:ncbi:121791">NiV</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 331 334 <span type="species:ncbi:121791">NiV</span>
###xml 456 459 <span type="species:ncbi:121791">NiV</span>
###xml 524 527 <span type="species:ncbi:121791">NiV</span>
###xml 593 596 <span type="species:ncbi:121791">NiV</span>
Here, we examined whether the NiV attachment protein G (NiV-G) can act as promiscuously as the Eph receptors in binding to other ephrins, in addition to ephrinB2. We showed that ephrinB2 and B3 bound to NiV-G with subnanomolar affinities. Expression of human ephrinB3 in nonpermissive CHO-pgsA745 cells rendered them permissive to NiV entry and infection. Lastly, we characterized the important conserved features of ephrinB2 and B3 that account for their NiV receptor activity. The discovery of a more comprehensive set of NiV receptors will aid our understanding of the pathology underlying NiV disease.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 0 3 <span type="species:ncbi:121791">NiV</span>
NiV-G Binds EphrinB3 at Lower Affinity than EphrinB2
###end title 11
###begin p 12
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b019">19</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b020">20</xref>
###xml 1142 1150 1142 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 1171 1172 1171 1172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1245 1246 1245 1246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 163 166 <span type="species:ncbi:121791">NiV</span>
###xml 285 288 <span type="species:ncbi:121791">NiV</span>
###xml 292 295 <span type="species:ncbi:121791">NiV</span>
###xml 426 429 <span type="species:ncbi:121791">NiV</span>
###xml 557 562 <span type="species:ncbi:9606">human</span>
###xml 623 638 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 939 942 <span type="species:ncbi:121791">NiV</span>
###xml 994 997 <span type="species:ncbi:121791">NiV</span>
###xml 1021 1026 <span type="species:ncbi:9606">human</span>
###xml 1059 1062 <span type="species:ncbi:121791">NiV</span>
###xml 1177 1180 <span type="species:ncbi:121791">NiV</span>
###xml 1305 1308 <span type="species:ncbi:121791">NiV</span>
Ephrins constitute a highly conserved class of proteins with many homologous members. Thus, we examined if any ephrins, other than ephrinB2, can bind similarly to NiV-G. Using an enzyme-linked immunosorbent assay (ELISA), we screened for the ability of soluble HA-tagged ectodomain of NiV-G (NiV-G-HA) to bind to all known ephrins (ephrinA1-A5 and ephrinB1-B3). We found that ephrinB3-Fc, in addition to ephrinB2-Fc, bound to NiV-G-HA (Figure 1A). To confirm these results with cell surface-expressed ephrins, CHO-pgsA745 cells were stably transfected with human ephrinB1 (CHO-B1), ephrinB2 (CHO-B2), or ephrinB3 (CHO-B3). Chinese hamster ovary (CHO) cells do not express ephrins endogenously [19], while the CHO-pgsA745 cells derived from these CHO cells lack heparin sulfate proteoglycans [20]. Heparin sulfates are known to act as entry or attachment receptors for many viruses, which can confound viral receptor studies. Thus, we used NiV-G-Fc, a fusion construct between the ectodomain of NiV-G and the Fc region of human IgG1, to measure the binding of NiV-G to each of the ephrin B-class ligands stably expressed on CHO-pgsA745 cells (Figure 1B). Remarkably, the Kd for NiV-G-Fc binding to ephrinB2 and B3 was in the subnanomolar range (Kd = 0.06 nM and 0.58 nM for ephrinB2 and B3, respectively). NiV-G-Fc did not bind to CHO-B1 cells when tested under the same conditions used for CHO-B2 and CHO-B3 cells (unpublished data).
###end p 12
###begin p 13
###xml 412 414 412 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">on</sub>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 525 533 525 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">1</xref>
###xml 549 552 549 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">off</sub>
###xml 599 601 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 603 605 603 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 663 665 663 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 667 669 667 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 944 945 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b021">21</xref>
###xml 113 116 <span type="species:ncbi:121791">NiV</span>
###xml 183 186 <span type="species:ncbi:121791">NiV</span>
###xml 291 294 <span type="species:ncbi:121791">NiV</span>
###xml 354 357 <span type="species:ncbi:121791">NiV</span>
###xml 580 583 <span type="species:ncbi:121791">NiV</span>
###xml 784 787 <span type="species:ncbi:121791">NiV</span>
To delineate the difference in binding affinities between ephrinB2 and B3, we examined their binding kinetics to NiV-G-Fc. We performed surface plasmon resonance analysis by coupling NiV-G-Fc to the sensor chip (as ligand) while using soluble ephrinB2 and B3 as analyte. BIAcore analysis of NiV-G-Fc binding to ephrinB2-Fc and B3-Fc indicated that while NiV-G-Fc bound to ephrinB2 and B3 with similar on-rates (Kon = 9.69 x 105 and 6.87 x 105 for ephrinB2 and B3, respectively), their off-rates were significantly different (Figure 1C and 1D). The Koff for ephrinB2-Fc binding to NiV-G-Fc (1.06 x 10-4 s-1) was more than 10-fold slower than ephrinB3-Fc (1.94 x 10-3 s-1) binding (Figure 1D). EphrinB1-Fc was also tested similarly to ephrinB2 and B3 and did not exhibit any binding to NiV-G-Fc even up to concentrations as high as 500 nM (unpublished data). As a control to determine the accuracy of our BIAcore measurements, we determined the Kd of EphB4-Fc binding to ephrinB2-Fc to be 0.37 nM, a value consistent with published values of approximately 0.5 nM [21] (unpublished data). Cumulatively, our data show that the Nipah attachment protein bound to both ephrinB2 and ephrinB3 with different but significant affinities.
###end p 13
###begin title 14
###xml 18 21 <span type="species:ncbi:121791">NiV</span>
EphrinB3 Supports NiV Entry and Infection
###end title 14
###begin p 15
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b021">21</xref>
###xml 546 554 546 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 89 92 <span type="species:ncbi:121791">NiV</span>
###xml 133 136 <span type="species:ncbi:121791">NiV</span>
###xml 730 733 <span type="species:ncbi:121791">NiV</span>
We next examined whether the high-affinity protein interaction seen between ephrinB3 and NiV-G was sufficient to permit the entry of NiV. We first established a panel of CHO-pgsA745 cells stably expressing ephrinB1, B2, and B3. Since the EphB3 receptor binds to all ephrin B-class ligands with similar affinities (0.27-1.8 nM for ephrinB1, 0.28-0.78 nM for ephrinB2, and 1.5 nM for ephrinB3) [21], we used saturating amounts of soluble EphB3 (EphB3-Fc) to determine the level of ephrinB1-B3 expression in our stable cell lines by flow cytometry (Figure 2A). We found that while CHO-B1, CHO-B2, and CHO-B3 cells were significantly positive for EphB3 binding (68%, 47%, and 47%, respectively), only CHO-B2 and CHO-B3 cells bound to NiV-G-Fc (46% and 31%, respectively). Soluble EphB3 did not bind to parental CHO-pgsA745 cells, nor did the ephrin A-class-specific EphA2-Fc bind any of the cell lines tested (CHO-pgsA745, CHO-B1, CHO-B2, or CHO-B3). These results confirm the specific ephrin B-class expression on our panel of CHO-pgsA745 cells.
###end p 15
###begin p 16
###xml 328 329 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b008">8</xref>
###xml 426 433 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 696 704 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 791 792 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 808 809 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1041 1049 1029 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 32 35 <span type="species:ncbi:121791">NiV</span>
###xml 48 51 <span type="species:ncbi:121791">NiV</span>
###xml 137 140 <span type="species:ncbi:121791">NiV</span>
###xml 200 226 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 228 231 <span type="species:ncbi:11276">VSV</span>
###xml 307 310 <span type="species:ncbi:121791">NiV</span>
###xml 311 314 <span type="species:ncbi:11276">VSV</span>
###xml 342 345 <span type="species:ncbi:121791">NiV</span>
###xml 346 349 <span type="species:ncbi:11276">VSV</span>
###xml 382 385 <span type="species:ncbi:121791">NiV</span>
###xml 401 404 <span type="species:ncbi:121791">NiV</span>
###xml 484 487 <span type="species:ncbi:121791">NiV</span>
###xml 509 512 <span type="species:ncbi:11276">VSV</span>
###xml 670 673 <span type="species:ncbi:121791">NiV</span>
###xml 674 677 <span type="species:ncbi:11276">VSV</span>
###xml 1053 1056 <span type="species:ncbi:121791">NiV</span>
###xml 1057 1060 <span type="species:ncbi:11276">VSV</span>
We then proceeded to quantitate NiV entry using NiV envelope pseudotyped luciferase (Luc) reporter viruses. We had previously shown that NiV envelopes can be successfully pseudotyped onto recombinant vesicular stomatitis virus (VSV) expressing a red fluorescent protein (RFP), but lacking its own envelope (NiV-VSV-DeltaG-RFP) [8]. Here, the NiV-VSV-DeltaG-Luc was made bearing the NiV fusion (F) and NiV-G and expressing the Renilla Luc reporter gene in place of the RFP gene. These NiV envelope pseudotyped VSV particles were used to infect CHO-pgsA745 parental cells (CHO), CHO-B1, CHO-B2, and CHO-B3 cell lines. We found that both CHO-B2 and CHO-B3 allowed entry of NiV-VSV-DeltaG-Luc virus (Figure 2B), although viral entry into CHO-B2 cells reproducibly resulted in higher Luc levels (p = 0.05, paired t-test). In three independent experiments, the reduction in viral entry into CHO-B3 cells ranged from 21% to 46%. Since the EphB3-Fc binding data indicated similar levels of ephrinB2 and B3 expression on the CHO-B2 and CHO-B3 cells (Figure 2A), NiV-VSV-DeltaG-Luc virus entered CHO-B2 cells more efficiently than CHO-B3 cells.
###end p 16
###begin p 17
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 62 65 <span type="species:ncbi:121791">NiV</span>
###xml 144 147 <span type="species:ncbi:121791">NiV</span>
###xml 161 167 <span type="species:ncbi:9606">humans</span>
###xml 434 437 <span type="species:ncbi:121791">NiV</span>
###xml 466 469 <span type="species:ncbi:121791">NiV</span>
###xml 949 952 <span type="species:ncbi:121791">NiV</span>
To examine whether ephrinB3 can support viral infection, live NiV infections were performed under Biosafety Level-4 conditions. The hallmark of NiV infection in humans is the presence of syncytial or multinucleated giant endothelial cells, and cell lines from many different species produced syncytia upon infection. Therefore, we looked for syncytia formation in CHO, CHO-B1, CHO-B2, CHO-B3, and Vero cells after infection with live NiV. Indeed, we found that live NiV can infect ephrinB2- and B3-expressing cells, although ephrinB2 appears to be used more efficiently (Figure 2C). With any given multiplicity of infection (MOI), at 24 h postinfection, there were always a greater number of syncytia in the CHO-B2 versus CHO-B3 cells. No syncytia were detected in CHO-B1 cells. At 48 h postinfection, syncytia were apparent at all MOIs tested in the CHO-B3 cells (unpublished data). Thus, ephrinB3 can serve as a bona fide alternative receptor for NiV entry.
###end p 17
###begin title 18
###xml 0 3 <span type="species:ncbi:121791">NiV</span>
NiV-G Binds EphrinB2 and B3 via an Overlapping Site
###end title 18
###begin p 19
###xml 384 392 380 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g003">Figure 3</xref>
###xml 668 676 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g003">Figure 3</xref>
###xml 53 56 <span type="species:ncbi:121791">NiV</span>
###xml 198 201 <span type="species:ncbi:121791">NiV</span>
###xml 202 205 <span type="species:ncbi:11276">VSV</span>
###xml 323 326 <span type="species:ncbi:121791">NiV</span>
###xml 449 452 <span type="species:ncbi:121791">NiV</span>
###xml 528 531 <span type="species:ncbi:121791">NiV</span>
###xml 583 586 <span type="species:ncbi:121791">NiV</span>
###xml 641 644 <span type="species:ncbi:121791">NiV</span>
###xml 765 768 <span type="species:ncbi:121791">NiV</span>
###xml 867 870 <span type="species:ncbi:121791">NiV</span>
Next, we asked whether ephrinB2 and B3 interact with NiV-G in a distinct or overlapping manner. To answer this question, we used a competition assay where CHO-B2 and CHO-B3 cells were infected with NiV-VSV-DeltaG-Luc viruses in the presence of soluble ephrin B-class ligands. As expected, ephrinB2-Fc inhibited pseudotyped NiV on CHO-B2 cells while ephrinB1-Fc did not inhibit entry (Figure 3, left). However, ephrinB3-Fc also inhibited pseudotyped NiV entry on CHO-B2 cells, suggesting that ephrinB3 blocked ephrinB2-dependent NiV entry by competing for a similar binding domain on NiV-G. Conversely, ephrinB2-Fc also inhibited pseudotyped NiV entry on CHO-B3 cells (Figure 3, right). In both CHO-B2 and CHO-B3 cells, ephrinB2-Fc was a more effective inhibitor of NiV-G entry than ephrinB3-Fc. In summary, these results suggest that ephrinB2 and B3 binding sites on NiV-G are overlapping.
###end p 19
###begin title 20
###xml 69 72 <span type="species:ncbi:121791">NiV</span>
Leu-Trp Residues in the G-H Loop of EphrinB2 and B3 Are Critical for NiV-G Binding
###end title 20
###begin p 21
###xml 317 325 317 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g004">Figure 4</xref>
###xml 515 523 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g004">Figure 4</xref>
###xml 647 650 647 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">124</sub>
###xml 654 657 654 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sub>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b022">22</xref>
###xml 846 847 846 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b008">8</xref>
###xml 34 37 <span type="species:ncbi:121791">NiV</span>
###xml 173 176 <span type="species:ncbi:121791">NiV</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 211 214 <span type="species:ncbi:10116">rat</span>
###xml 821 824 <span type="species:ncbi:121791">NiV</span>
###xml 912 915 <span type="species:ncbi:121791">NiV</span>
###xml 1021 1024 <span type="species:ncbi:121791">NiV</span>
Since ephrinB2 and B3 can support NiV entry, while ephrinB1 cannot, we hypothesize that conserved residues common in both ephrinB2 and B3 mediate specific interactions with NiV-G. Alignment of human, mouse, and rat ephrinB1, B2, and B3 sequences identified common residues in ephrinB2 and B3 not present in ephrinB1 (Figure 4A). Examination of the homologous G-H loop regions between ephrinB1, B2, and B3 reveals that the L-W (Leu-Trp) residues present in ephrinB2 and B3 are replaced by Y-M (Tyr-Met) in ephrinB1 (Figure 4A). The cocrystal structure of ephrinB2 and the EphB2 receptor (an endogenous ephrinB2 receptor) indicates that the L-W (Leu124-Trp125) residues in the G-H loop of ephrinB2 insert deep into a hydrophobic pocket in EphB2 [22]. We believe this interaction to be informative as soluble EphB2 inhibits NiV-G mediated infection[8] and is likely to interact with a similar region on ephrinB2 as NiV-G. Thus, we sought to determine if the G-H loop L-W residues in ephrinB2 and ephrinB3 also interact with NiV-G.
###end p 21
###begin p 22
###xml 260 262 260 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LW</sub>
###xml 315 323 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g004">Figure 4</xref>
###xml 387 389 387 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 410 412 410 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 485 487 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 278 281 <span type="species:ncbi:121791">NiV</span>
###xml 438 441 <span type="species:ncbi:121791">NiV</span>
###xml 517 520 <span type="species:ncbi:121791">NiV</span>
Full-length human ephrinB1, B2, and B3 clones were obtained, and the ectodomain of each was fused to the Fc region of human IgG1. Replacement of Y-M in ephrinB1 with L-W from the homologous positions in ephrinB2 and B3 resulted in a soluble ephrinB1 mutant, B1LW-Fc, that bound NiV-G almost as well as ephrinB2-Fc (Figure 4B). Conversely, the L-W to Y-M mutations in soluble ephrinB2 (B2YM-Fc) and ephrinB3 (B3YM-Fc) abrogated binding to NiV-G-HA, although at higher concentrations, B2YM-Fc appears to retain minimal NiV-G binding activity.
###end p 22
###begin title 23
###xml 63 66 <span type="species:ncbi:121791">NiV</span>
Leu-Trp Residues in the G-H Loop of EphrinB3 Are Necessary for NiV Entry
###end title 23
###begin p 24
###xml 233 235 233 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LW</sub>
###xml 243 245 243 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 257 259 257 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b021">21</xref>
###xml 722 730 722 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g005">Figure 5</xref>
###xml 749 751 749 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LW</sub>
###xml 761 763 761 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 777 779 777 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 1011 1019 1011 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g004">Figure 4</xref>
###xml 124 127 <span type="species:ncbi:121791">NiV</span>
###xml 898 901 <span type="species:ncbi:121791">NiV</span>
Next, we examined the effects of these L-W/Y-M mutations in the context of full-length ephrins and their ability to support NiV entry. To do so, we first made stable CHO-pgsA745 cells expressing the full-length ephrin mutants (CHO-B1LW, CHO-B2YM, and CHO-B3YM). We compared the level of mutant ephrin expression in the stable cell lines to that of wild-type ephrin expression using EphB3-Fc in a flow cytometry analysis. It is unlikely that EphB3 binds to the ephrin LW/YM residues in question since EphB3 can bind ephrinB1, B2, and B3 with similar affinities [21]. Therefore, using EphB3-Fc to measure cell surface expression, we found that both wild-type ephrin and its relevant mutant were expressed at similar levels (Figure 5A; compare B1 to B1LW, B2 to B2YM, and B3 to B3YM). Parental CHO-pgsA745 (CHO) served as a negative control and soluble EphB3 did not bind to these cells. In addition, NiV-G-Fc bound to the mutant ephrins in the expected patterns seen in our previous solid state ELISA experiment (Figure 4B).
###end p 24
###begin p 25
###xml 78 86 78 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g005">Figure 5</xref>
###xml 187 195 187 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 205 207 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LW</sub>
###xml 259 261 259 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 303 305 303 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 364 366 364 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YM</sub>
###xml 544 547 544 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">124</sub>
###xml 549 552 549 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sub>
###xml 713 715 713 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LW</sub>
###xml 842 844 842 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LW</sub>
###xml 45 48 <span type="species:ncbi:121791">NiV</span>
###xml 49 52 <span type="species:ncbi:11276">VSV</span>
###xml 134 137 <span type="species:ncbi:121791">NiV</span>
###xml 229 232 <span type="species:ncbi:121791">NiV</span>
###xml 600 603 <span type="species:ncbi:121791">NiV</span>
###xml 681 684 <span type="species:ncbi:121791">NiV</span>
###xml 806 809 <span type="species:ncbi:121791">NiV</span>
###xml 1005 1008 <span type="species:ncbi:121791">NiV</span>
We then proceeded to infect these cells with NiV-VSV-Luc pseudotyped viruses (Figure 5B). As expected, both ephrinB2 and B3 permitted NiV envelope-mediated entry as described previously (Figure 2B). The B1LW mutant now supported NiV entry, while entry into B2YM cells was markedly reduced. Entry into B3YM was completely abrogated. We note that while entry into B2YM cells was reduced by about 85% compared to wild-type ephrinB2 cells, entry was still 44-fold over background (parental CHO-pgsA745 cells). These results suggest that while the L124-W125 residues in ephrinB3 appear to be critical for NiV entry, other residues in ephrinB2 likely have a supporting role in mediating NiV entry. Interestingly, the B1LW mutant could not fully restore entry equivalent to wild-type B2 or B3 levels, even though NiV-G bound to cell surface ephrinB1LW at wild-type ephrinB2 levels. Therefore, in addition to simple binding, additional residues in ephrinB2 likely mediate the subsequent conformational changes in NiV-G and/or F that leads to membrane fusion and entry.
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b008">8</xref>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b009">9</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b010">10</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b011">11</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b007">7</xref>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 71 74 <span type="species:ncbi:121791">NiV</span>
###xml 211 214 <span type="species:ncbi:121791">NiV</span>
###xml 287 290 <span type="species:ncbi:121791">NiV</span>
###xml 328 331 <span type="species:ncbi:121791">NiV</span>
###xml 392 395 <span type="species:ncbi:121791">NiV</span>
###xml 489 492 <span type="species:ncbi:121791">NiV</span>
###xml 640 643 <span type="species:ncbi:121791">NiV</span>
###xml 776 779 <span type="species:ncbi:121791">NiV</span>
###xml 815 818 <span type="species:ncbi:121791">NiV</span>
###xml 887 890 <span type="species:ncbi:121791">NiV</span>
EphrinB2 was recently identified as a functional cellular receptor for NiV [8,9]. EphrinB2 expression on endothelial cells, neurons and smooth muscle cells [10,11] is highly consistent with the known tropism of NiV infection [7]. Here, we show that ephrinB3 is an alternate receptor for NiV and is independently able to support NiV entry and infection, albeit less efficiently than ephrinB2. NiV-G binds to both ephrinB2 and B3 with subnanomolar affinity, with the relatively weaker Kd of NiV-G for ephrinB3 explained by its faster off-rate. Finally, we implicate two residues (L-W) common in the G-H loop of ephrinB2 and B3 as crucial for NiV receptor activity. Remarkably, replacement of the Y-M residues in the homologous positions in ephrinB1 with L-W conferred wild-type NiV-G binding activity and substantial NiV receptor activity to a protein that is otherwise nonfunctional as a NiV receptor.
###end p 27
###begin p 28
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b023">23</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b024">24</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b008">8</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b018">18</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b025">25</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b026">26</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b027">27</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b028">28</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b027">27</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b016">16</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b017">17</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 304 307 <span type="species:ncbi:121791">NiV</span>
###xml 829 832 <span type="species:ncbi:121791">NiV</span>
###xml 953 956 <span type="species:ncbi:121791">NiV</span>
###xml 1130 1133 <span type="species:ncbi:121791">NiV</span>
To our knowledge, there is no specific indication that ephrinB3 is expressed in the endothelium. At the minimum, ephrinB3 does not appear to be critical to vascular development since ephrinB3 knockout mice lack the overt defects in vascular morphogenesis seen in ephrinB2 knockout mice [23,24]. However, NiV entry into microvascular endothelial cells is almost completely abrogated by soluble ephB4-Fc [8], which binds to ephrinB2 but not B3, suggesting that ephrinB3 is likely not expressed on endothelial cells, at least not at levels that can support robust viral entry. In contrast, ephrinB3 is expressed in the CNS in overlapping and distinct patterns with ephrinB2 [18,25]. In the regions of the adult brain such as the cerebral cortex [26,27] and the hippocampus [28] where ephrinB2 and B3 exhibit overlapping expression, NiV could potentially use either receptor for entry with a possible preference for ephrinB2 based on the higher affinity of NiV-G for ephrinB2. However, in regions such as the corpus callosum [27] and the spinal cord [16,17], ephrinB3 is distinctly expressed and could account for specific aspects of NiV pathology.
###end p 28
###begin p 29
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b007">7</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b029">29</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b030">30</xref>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b031">31</xref>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b027">27</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 210 213 <span type="species:ncbi:121791">NiV</span>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
###xml 645 652 <span type="species:ncbi:9606">patient</span>
###xml 814 822 <span type="species:ncbi:9606">patients</span>
###xml 828 831 <span type="species:ncbi:121791">NiV</span>
###xml 855 863 <span type="species:ncbi:9606">patients</span>
###xml 1037 1040 <span type="species:ncbi:121791">NiV</span>
###xml 1151 1154 <span type="species:ncbi:121791">NiV</span>
EphrinB3 knockout mice studies indicate ephrinB3 is expressed in the spinal cord midline and functions to prevent corticospinal tract axons from recrossing the midline. Coincidently, in a histological study of NiV infection by Wong et al., three of eight patients examined showed pathological lesions in the spinal cord similar to other regions of the CNS [7]. Indeed, clinical symptoms of segmental myoclonus and flaccid tetraplegia combined with nerve conduction studies have also suggested upper cervical and lower spinal cord involvement [29], and magnetic resonance imaging confirmation of a spinal cord lesion at the cognate C7 level in a patient who developed left-arm dysaesthesia and finger weakness has also been reported [30]. In another study that reported magnetic resonance imaging findings in eight patients with NiV encephalitis, half the patients had numerous punctate lesions in the corpus callosum [31], where ephrinB3, but not ephrinB2, is expressed [27]. Thus, although ephrinB2 seems to be the primary receptor for NiV, ephrinB3 can likely be used as an alternative receptor and may account for some of the CNS pathology seen in NiV infection.
###end p 29
###begin p 30
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b021">21</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b022">22</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b032">32</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b010">10</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b011">11</xref>
###xml 40 43 <span type="species:ncbi:121791">NiV</span>
###xml 188 191 <span type="species:ncbi:121791">NiV</span>
###xml 292 295 <span type="species:ncbi:121791">NiV</span>
###xml 376 379 <span type="species:ncbi:121791">NiV</span>
In this study, we also established that NiV-G binding to ephrinB2 and B3 is dependent on the same L-W residues that are important for endogenous ephrinB2/EphB2 interactions [21,22]. Since NiV-G interacts with ephrinB2 in a similar fashion with at least some of the Eph B-class receptors, and NiV-G forms higher order oligomers [32] analogous to Eph B-class receptors [10,11], NiV-G could potentially induce "reverse-signaling" upon ephrinB2 or B3 binding.
###end p 30
###begin p 31
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b010">10</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b011">11</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b033">33</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b035">35</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b036">36</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b027">27</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b037">37</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b038">38</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b039">39</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b040">40</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b041">41</xref>
###xml 163 166 <span type="species:ncbi:121791">NiV</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
###xml 781 784 <span type="species:ncbi:121791">NiV</span>
###xml 966 969 <span type="species:ncbi:121791">NiV</span>
In vivo, Eph-ephrin interactions cause bidirectional signaling that can direct the migration of endothelial cells and neuronal dendrites [10,11,33-35]. Therefore, NiV infection may not only target ephrinB2- or B3-expressing cells, but also disrupt normal Eph-ephrin signaling and possibly alter cellular migration patterns. Indeed, infusion of soluble EphB2-Fc has been reported to disrupt the migration of ephrinB2- and B3-expressing cells of the subventricular zone region in an adult mouse [36]. Although the levels of Ephs and ephrins in other regions of the adult brain are reduced compared to neonatal-stage expression [27], Eph and ephrins can alter their expression patterns after injury to the spinal cord [37], hippocampus [38], or after infection [39,40]. In this case, NiV infection may alter ephrin expression patterns in the CNS and disrupt the endogenous Eph-ephrin signaling resulting in the neuropsychiatric [41] or neuropathologic sequelae seen in NiV infections.
###end p 31
###begin p 32
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b042">42</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b043">43</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b044">44</xref>
###xml 42 45 <span type="species:ncbi:121791">NiV</span>
###xml 351 354 <span type="species:ncbi:121791">NiV</span>
###xml 522 525 <span type="species:ncbi:121791">NiV</span>
###xml 543 546 <span type="species:ncbi:121791">NiV</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Zoonotic diseases such as those caused by NiV have become an increasing threat in several parts of the world [42]. The habitat of the pteropid fruit bat, considered as the natural reservoir host, spans from the east coast of Africa across southern and Southeast Asia, east to the Philippines and Pacific islands, and south to Australia [43]. Although NiV outbreaks have only occurred in Malaysia, Bangladesh, and Singapore, increased surveillance in other geographical regions of the pteropid habitat found bats to harbor NiV [44]. Therefore, NiV continues to remain a potential threat to both human and animal populations. This underscores the need for the development of antiviral therapeutics. A complete understanding of Nipah viral entry at the level of receptor engagement may help in these efforts.
###end p 32
###begin title 33
Materials and Methods
###end title 33
###begin title 34
Cells and culture conditions.
###end title 34
###begin p 35
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b019">19</xref>
###xml 923 924 919 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 160 180 <span type="species:ncbi:9534">African green monkey</span>
###xml 356 362 <span type="species:ncbi:9913">bovine</span>
CHO-pgsA745 is a mutant cell line derived from CHO cells that lack the endogenous expression of heparin sulfate proteogylcans [19]. CHO-pgsA745 cells and Vero (African green monkey kidney fibroblasts) cells were maintained in DMEM/F12 and alpha-MEM (Invitrogen, Carlsbad, California, United States), respectively, and both were supplemented with 10% fetal bovine serum (Omega Scientific, Tarzana, California, United States) and the antibiotics penicillin and streptomycin. CHO-pgsA745 cells expressing either wild-type or mutant ephrins were made by selecting for neomycin resistance with 0.5 mg/ml of G418 after transfection. Once selected, the ephrin-expressing populations were enriched using the magnetic bead selection (Miltenyi Biotech, Auburn, California, United States). Briefly, EphB3-Fc (R & D Systems, Minneapolis, Minnesota, United States) was coupled to protein G microbeads (Miltenyi Biotech), and then 2 x 106 ephrin-expressing CHO-pgsA745 cells were added. Then, the cell-bead mixture was poured over a MACS MS column (Miltenyi Biotech), followed by positive cells elution.
###end p 35
###begin title 36
Plasmids and reagents.
###end title 36
###begin p 37
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b008">8</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b045">45</xref>
###xml 140 145 <span type="species:ncbi:9606">Human</span>
###xml 252 257 <span type="species:ncbi:9606">human</span>
###xml 428 431 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 618 623 <span type="species:ncbi:9606">human</span>
Soluble Fc-fusion ephrin proteins (ephrinA1-A5 and ephrinB1-B3) and Eph proteins (EphA2-Fc and EphB3-Fc) were purchased from R & D Systems. Human ephrinB2 and ephrinB3 plasmids were purchased from GeneCopoeia (Germantown, Maryland, United States), and human ephrinB1 was obtained from Open Biosystems (Huntsville, Alabama, Unites States). Each ephrin open reading frame was subcloned into the pcDNA3.1 vector (Invitrogen) under CMV promoter-driven expression. In-house ephrin-Fc fusion constructs were made by subcloning the ectodomain of each ephrin into the pCR3-Fc vector, which contains the CH2 and CH3 domains of human IgG1. Mutations in both the full-length (pcDNA3.1 clones) and soluble (pCR3-Fc clones) [8,45] were made using the QuikChange (Stratagene, La Jolla, California, United States) site-directed mutagenesis kit. All subclones and mutations were confirmed by sequencing.
###end p 37
###begin title 38
###xml 30 33 <span type="species:ncbi:121791">NiV</span>
Binding of soluble ephrins to NiV-G.
###end title 38
###begin p 39
###xml 17 20 <span type="species:ncbi:121791">NiV</span>
###xml 202 205 <span type="species:ncbi:121791">NiV</span>
###xml 251 257 <span type="species:ncbi:9913">bovine</span>
###xml 492 495 <span type="species:ncbi:121791">NiV</span>
Supernatant from NiV-G-HA-transfected 293T cells was used to coat MaxiSorp high protein-binding 96-well plates (Nalg Nunc International, Rochester, New York, United States) overnight at 4 degreesC. The NiV-G-HA-coated plates were then blocked with 5% bovine serum albumin (BSA) in Tris-buffer saline (TBS) for 2 h at 37 degreesC. The plates were rinsed with wash buffer (1% BSA, 0.05% Tween-20 in TBS), and ephrin-Fc proteins, diluted in wash buffer, were placed in each well to bind soluble NiV-G for 1 h at room temperature. The plates were washed three times with wash buffer and incubated with antihuman Fc monoclonal antibody conjugated with HRP for 30 min at room temperature. The plates were then washed three more times, and the amount of bound ephrin was assessed with 1-step Ultra TMB substrate (Pierce, Rockford, Illinois, United States). The colorimetric reading was performed on a spectrophotometer (Dynex Technologies, Chantilly, Virginia, United States). For each soluble ephrin-Fc, each experiment was performed three times, each time in triplicates.
###end p 39
###begin title 40
Cell surface binding assays.
###end title 40
###begin p 41
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 140 143 <span type="species:ncbi:121791">NiV</span>
The ephrinB2- and B3-expressing CHO-pgsA745 cells (CHO-B2 and CHO-B3, respectively) were made as described above. Increasing amounts of the NiV-G-Fc were incubated with CHO-B2 or CHO-B3 cells for 1 h on ice. Then, the cells were washed with buffer and incubated with R-phycoerythrin-conjugated anti-Fc antibodies for 30 min on ice. The cells were washed again and fixed with 2% paraformaldehyde, and the data were collected using a FACScan flow cytometer (Becton Dickinson, Franklin Lakes, New Jersey, United States). The data were analyzed using FCS Express V2 (DeNovo Software, Thornhill, Ontario, Canada). The cell surface Kd values were calculated using the GraphPad Prism software (San Diego, California, United States) by normalizing the highest mean fluorescent intensity value obtained to 100%.
###end p 41
###begin title 42
Pseudotyped virus infection assay.
###end title 42
###begin p 43
###xml 219 226 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 742 749 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 0 3 <span type="species:ncbi:121791">NiV</span>
###xml 45 48 <span type="species:ncbi:11276">VSV</span>
###xml 81 84 <span type="species:ncbi:11276">VSV</span>
###xml 143 146 <span type="species:ncbi:11276">VSV</span>
###xml 279 282 <span type="species:ncbi:121791">NiV</span>
###xml 333 336 <span type="species:ncbi:11276">VSV</span>
###xml 344 347 <span type="species:ncbi:121791">NiV</span>
###xml 535 538 <span type="species:ncbi:11276">VSV</span>
###xml 546 549 <span type="species:ncbi:121791">NiV</span>
NiV pseudotyped particles were made from the VSV-DeltaG-Luc virus, a recombinant VSV derived from a full-length complementary DNA clone of the VSV Indiana serotype in which the G-protein envelope has been replaced with Renilla Luc (kindly provided by Andrea Bertolotti-Ciarlet). NiV envelopes F and G were provided in trans, and the VSV-DeltaG-NiV pseudotyped viruses were then used to infect the various CHO-pgsA745 cell lines. Briefly, the cells were seeded overnight in a 48-well plate and then infected for 1 h at 37 degreesC with VSV-DeltaG-NiV diluted in 1% FBS in phosphate buffer saline (PBS). The inoculum was removed and washed with PBS and replaced by culture media. The next day, the cells were lysed, the lysates were mixed with Renilla Luc subtrate (Promega, Madison, Wisconsin, United States), and a luminescence reading was performed on a Veritas luminometer (Turner BioSystems, Sunnyvale, California, United States). Each condition was done in triplicate and infections were repeated three times.
###end p 43
###begin title 44
###xml 5 8 <span type="species:ncbi:121791">NiV</span>
Live NiV infection assay.
###end title 44
###begin p 45
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 129 132 <span type="species:ncbi:121791">NiV</span>
###xml 301 304 <span type="species:ncbi:121791">NiV</span>
Parental CHO-pgsA745, ephrin-expressing CHO-pgsA745, and Vero cells were seeded at 105 cells per well in 24-well plates for live NiV infections. In the L4 facility of the Philipps-University Marburg under Biosafety Level 4 (BSL-4) conditions, the cells were then infected with a different MOI of live NiV (kindly obtained from Andrea Maisner) and incubated for 2 h. The inoculum was removed, and the cells were washed three times with PBS and left with 1 ml of DMEM/F12 supplemented with 2% FBS. At 24 h postinfection, the cells were washed once with PBS and incubated with 100% ethanol for 10 min at room temperature. After removal of the ethanol, nuclei were stained with Giemsa solution (1:10 dilution in water) at room temperature for 30 min. Excess staining solution was rinsed off with water, and the cells were allowed to dry for 10-15 min before evaluation of syncytia formation under a light microscope.
###end p 45
###begin title 46
Surface plasmon resonance.
###end title 46
###begin p 47
###xml 511 512 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 515 517 514 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">on</sub>
###xml 543 546 542 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">off</sub>
###xml 125 128 <span type="species:ncbi:121791">NiV</span>
A BIAcore 3000 instrument (Biacore, Piscataway, New Jersey, United States) was used to perform binding kinetics experiments. NiV-G-Fc diluted in sodium acetate (pH 4.0) was immobilized onto a carboxymethylated dextran (CM5) surface by standard amine coupling immobilization procedure. The ephrin analytes were diluted in HBS-EP buffers (BIAcore), and the injections were performed at a flow rate of 50 mul/min for 180 s. Surfaces were regenerated using 20 mM sodium hydroxide (BIAcore). Dissociation constants Kd, Kon (association-rate), and Koff (dissociation-rate) were determined by fitting binding chromatogram data with BIAcore evaluation software (version 3.1) using the 1:1 Langmuir binding model.
###end p 47
###begin p 48
We thank members of the laboratory for support and encouragement.
###end p 48
###begin title 49
Abbreviations
###end title 49
###begin p 50
###xml 0 15 <span type="species:ncbi:10029">Chinese hamster</span>
Chinese hamster ovary
###end p 50
###begin p 51
central nervous system
###end p 51
###begin p 52
enzyme-linked immunosorbent assay
###end p 52
###begin p 53
luciferase
###end p 53
###begin p 54
multiplicity of infection
###end p 54
###begin p 55
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus
###end p 55
###begin p 56
###xml 0 3 <span type="species:ncbi:121791">NiV</span>
NiV attachment protein G
###end p 56
###begin p 57
red fluorescent protein
###end p 57
###begin p 58
###xml 0 26 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
vesicular stomatitis virus
###end p 58
###begin title 59
References
###end title 59
###begin article-title 60
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus: A recently emergent deadly paramyxovirus
###end article-title 60
###begin article-title 61
###xml 30 41 <span type="species:ncbi:121791">Nipah virus</span>
Molecular characterization of Nipah virus, a newly emergent paramyxovirus
###end article-title 61
###begin article-title 62
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 90 101 <span type="species:ncbi:121791">Nipah virus</span>
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia
###end article-title 62
###begin article-title 63
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus encephalitis reemergence, Bangladesh
###end article-title 63
###begin article-title 64
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus-A potential agent of bioterrorism?
###end article-title 64
###begin article-title 65
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis
###end article-title 65
###begin article-title 66
###xml 35 46 <span type="species:ncbi:121791">Nipah virus</span>
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
###end article-title 66
###begin article-title 67
###xml 46 58 <span type="species:ncbi:63330">Hendra virus</span>
###xml 63 74 <span type="species:ncbi:121791">Nipah virus</span>
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
###end article-title 67
###begin article-title 68
Diverse roles of Eph receptors and ephrins in the regulation of cell migration and tissue assembly
###end article-title 68
###begin article-title 69
Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function
###end article-title 69
###begin article-title 70
Comparative pathology of the diseases caused by Hendra and Nipah viruses
###end article-title 70
###begin article-title 71
The ephrins and Eph receptors in neural development
###end article-title 71
###begin article-title 72
The ephrins and Eph receptors in angiogenesis
###end article-title 72
###begin article-title 73
The role of ephrins and Eph receptors in cancer
###end article-title 73
###begin article-title 74
Forward signaling mediated by ephrin-B3 prevents contralateral corticospinal axons from recrossing the spinal cord midline
###end article-title 74
###begin article-title 75
Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control
###end article-title 75
###begin article-title 76
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
Distinct and overlapping expression patterns of ligands for Eph-related receptor tyrosine kinases during mouse embryogenesis
###end article-title 76
###begin article-title 77
Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis
###end article-title 77
###begin article-title 78
Animal cell mutants defective in glycosaminoglycan biosynthesis
###end article-title 78
###begin article-title 79
Ephrins and their receptors: Binding versus biology
###end article-title 79
###begin article-title 80
Crystal structure of an Eph receptor-ephrin complex
###end article-title 80
###begin article-title 81
Role of EphA4 and EphrinB3 in local neuronal circuits that control walking
###end article-title 81
###begin article-title 82
Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
###end article-title 82
###begin article-title 83
Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube
###end article-title 83
###begin article-title 84
cDNA cloning, chromosomal localization, and expression pattern of EPLG8, a new member of the EPLG gene family encoding ligands of EPH-related protein-tyrosine kinase receptors
###end article-title 84
###begin article-title 85
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
mRNA expression of ephrins and Eph receptor tyrosine kinases in the neonatal and adult mouse central nervous system
###end article-title 85
###begin article-title 86
Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity
###end article-title 86
###begin article-title 87
###xml 21 32 <span type="species:ncbi:121791">Nipah virus</span>
###xml 52 55 <span type="species:ncbi:9823">pig</span>
Clinical features of Nipah virus encephalitis among pig farmers in Malaysia
###end article-title 87
###begin article-title 88
###xml 58 69 <span type="species:ncbi:121791">Nipah virus</span>
Late clinical and magnetic resonance imaging follow up of Nipah virus infection
###end article-title 88
###begin article-title 89
###xml 28 49 <span type="species:ncbi:11072">Japanese encephalitis</span>
Nipah viral encephalitis or Japanese encephalitis? MR findings in a new zoonotic disease
###end article-title 89
###begin article-title 90
###xml 81 92 <span type="species:ncbi:121791">Nipah virus</span>
Novel innate immune functions for galectin-1: Galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines
###end article-title 90
###begin article-title 91
EphB receptors and ephrinB ligands: Regulators of vascular assembly and homeostasis
###end article-title 91
###begin article-title 92
Mechanisms and functions of Eph and ephrin signalling
###end article-title 92
###begin article-title 93
Eph receptors and ephrins restrict cell intermingling and communication
###end article-title 93
###begin article-title 94
Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone
###end article-title 94
###begin article-title 95
Induction of Eph B3 after spinal cord injury
###end article-title 95
###begin article-title 96
Up-regulation of Eph tyrosine kinase receptors after excitotoxic injury in adult hippocampus
###end article-title 96
###begin article-title 97
###xml 91 95 <span type="species:ncbi:10116">rats</span>
Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats
###end article-title 97
###begin article-title 98
###xml 53 58 <span type="species:ncbi:9606">human</span>
Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: Phenotype switch from venous to arterial endothelium
###end article-title 98
###begin article-title 99
###xml 29 40 <span type="species:ncbi:121791">Nipah virus</span>
Neuropsychiatric sequelae of Nipah virus encephalitis
###end article-title 99
###begin article-title 100
Conservation medicine and a new agenda for emerging diseases
###end article-title 100
###begin article-title 101
The natural history of Hendra and Nipah viruses
###end article-title 101
###begin article-title 102
###xml 0 11 <span type="species:ncbi:121791">Nipah virus</span>
Nipah virus in Lyle's flying foxes, Cambodia
###end article-title 102
###begin article-title 103
###xml 24 53 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN
###end article-title 103
###begin title 104
Figures and Tables
###end title 104
###begin title 105
###xml 8 11 <span type="species:ncbi:121791">NiV</span>
Soluble NiV-G Binds to EphrinB3 with Lower Affinity than EphrinB2
###end title 105
###begin p 106
###xml 163 184 160 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 119 122 <span type="species:ncbi:121791">NiV</span>
###xml 289 300 <span type="species:ncbi:3704">horseradish</span>
(A) 1.0 mug/ml, 0.1 mug/ml, and 0.01 mug/ml of the indicated ephrin-Fc fusion proteins were allowed to bind to soluble NiV-G-coated plates in an ELISA format (see Materials and Methods). The amount of ligand bound was detected colorimetrically using an antihuman Fc antibody conjugated to horseradish peroxidase. One representative experiment out of three is shown. Data are averages of triplicates +/- standard error (SE).
###end p 106
###begin p 107
###xml 112 115 <span type="species:ncbi:121791">NiV</span>
###xml 172 175 <span type="species:ncbi:121791">NiV</span>
(B) EphrinB2 and B3 stably transfected CHO-pgsA745 cells (CHO-B2 and CHO-B3, respectively) were used to measure NiV-G-Fc cell surface binding. Increasing concentrations of NiV-G-Fc were added to either CHO-B2 cells (dashed line with squares) or CHO-B3 cells (solid line with triangles), and binding was assessed by flow cytometry using R-phycoerythrin-conjugated anti-Fc antibodies. Regression curves were generated as described in Materials and Methods. Each data point is an average +/- SE from three experiments.
###end p 107
###begin p 108
###xml 78 81 <span type="species:ncbi:121791">NiV</span>
###xml 147 150 <span type="species:ncbi:121791">NiV</span>
(C) Surface plasmon resonance (BIAcore 3000) measured the binding kinetics of NiV-G-Fc to both ephrinB2-Fc and ephrinB3-Fc in response units (RU). NiV-G-Fc was immobilized to a CM5 sensor chip via an amide coupling procedure, and increasing concentrations of ephrinB2-Fc and ephrinB3-Fc were flowed as analyte over the sensor chip. One representative experiment out of two is shown.
###end p 108
###begin p 109
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 11 13 11 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">on</sub>
###xml 40 43 40 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">off</sub>
(D) K d, K on (association-rate), and K off (dissociation-rate) were determined by fitting the binding chromatogram data from (C) with BIAcore evaluation software (version 3.1) using the 1:1 Langmuir binding model.
###end p 109
###begin title 110
###xml 21 24 <span type="species:ncbi:121791">NiV</span>
Pseudotyped and Live NiV Use EphrinB2 and B3 for Cellular Entry
###end title 110
###begin p 111
###xml 343 351 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 192 206 <span type="species:ncbi:10029">CHO cell lines</span>
###xml 260 263 <span type="species:ncbi:121791">NiV</span>
(A) Ephrin expression was measured by flow cytometry on CHO-pgsA745 parental cells (CHO) and CHO-pgsA745 cells stably expressing ephrinB1, B2, and B3 (CHO-B1, CHO-B2, and CHO-B3). To bind the CHO cell lines, 10 mug/ml of EphA2, 10 mug/ml EphB3-Fc, and 1 nM of NiV-G-Fc were used, and the amount of binding was detected by flow cytometry as in Figure 1B. Data are representative of three experiments.
###end p 111
###begin p 112
###xml 273 280 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 651 652 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 668 669 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 4 7 <span type="species:ncbi:121791">NiV</span>
###xml 54 57 <span type="species:ncbi:11276">VSV</span>
###xml 81 84 <span type="species:ncbi:121791">NiV</span>
###xml 85 88 <span type="species:ncbi:11276">VSV</span>
###xml 218 221 <span type="species:ncbi:121791">NiV</span>
###xml 222 225 <span type="species:ncbi:11276">VSV</span>
(B) NiV-F and G glycoproteins were pseudotyped onto a VSV-DeltaG-Luc core virus (NiV-VSV-DeltaG-Luc) and used to infect parental CHO-pgsA745 (CHO), CHO-B1, CHO-B2, and CHO-B3 cells. Entry of the indicated dilutions of NiV-VSV-DeltaG-Luc viruses was measured by quantifying Renilla Luc activity according to manufacturer's directions. Relative light units (RLU) were acquired and quantified on a Veritas luminometer. Data are shown as averages of triplicates +/- standard deviation of a representative experiment. In three independent experiments, viral entry into CHO-B3 cells was reduced by 21%, 28%, and 46%, respectively, compared to CHO-B2 cells (p = 0.05, paired t-test).
###end p 112
###begin p 113
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 28 31 <span type="species:ncbi:121791">NiV</span>
###xml 194 197 <span type="species:ncbi:121791">NiV</span>
(C) The listed MOIs of live NiV were used to infect the indicated cell lines (105 cells per infection). Foci of syncytia were observed 24 h postinfection. Vero E6 cells are fully permissive for NiV infection and were used as positive control cells. Note the larger number of syncytia seen on CHO-B2 versus CHO-B3 cells.
###end p 113
###begin title 114
###xml 21 24 <span type="species:ncbi:121791">NiV</span>
EphrinB2 and B3 Bind NiV-G at an Overlapping Site
###end title 114
###begin p 115
###xml 233 241 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 0 3 <span type="species:ncbi:121791">NiV</span>
###xml 4 7 <span type="species:ncbi:11276">VSV</span>
NiV-VSV-DeltaG-Luc pseudotyped viruses were used to infect CHO-B2 and CHO-B3 cells in the presence of the indicated amounts of ephrinB1, B2, and B3-Fc fusion proteins (B1-Fc, B2-Fc, and B3-Fc, respectively). Entry was measured as in Figure 2A. Data are the average of triplicates +/- standard deviation, and one representative experiment of three is shown.
###end p 115
###begin title 116
###xml 97 100 <span type="species:ncbi:121791">NiV</span>
The Leu-Trp Residues Present in the G-H Loop of EphrinB2 and B3 Are the Critical Determinants of NiV-G Binding
###end title 116
###begin p 117
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020007-b022">22</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 54 57 <span type="species:ncbi:10116">rat</span>
(A) Sequence alignment of human (hu), mouse (ms), and rat (rt) ephrinB1, B2, and B3 ectodomains using the Jotun Hein algorithm (DNAstar Megalign software). Six residues in the ephrin B-class ectodomain reveal solvent-exposed amino acids [22] that contain identical residues in both ephrinB2 and B3 but different residues in ephrinB1 (open box). Examination of the ephrin binding loop (G-H loop) indicates the L-W residues in ephrin B2 and B3 are replaced by Y-M residues in ephrinB1 (filled box).
###end p 117
###begin p 118
###xml 478 486 478 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 406 409 <span type="species:ncbi:121791">NiV</span>
(B) Ephrin-Fc mutants were created by substituting the L-W residues present in ephrinB2 and B3 with Y-M residues using site-directed mutagenesis (B2YM-Fc and B3YM-Fc). Conversely, the Y-M residues in ephrinB1 were exchanged for the L-W residues (B1LW-Fc); 10 nM, 1 nM, and 0.1 nM of both wild-type (B1, B2, and B3) and mutant (B1LW, B2YM, and B3YM) ephrin-Fc proteins were tested for their ability to bind NiV-G-HA in an ELISA. The amount of binding was measured the same as in Figure 1A. The data are averages of three experiments done in triplicates +/- standard error.
###end p 118
###begin title 119
###xml 75 78 <span type="species:ncbi:121791">NiV</span>
The Leu-Trp Residues in G-H loop of EphrinB3 Are Necessary for Pseudotyped NiV Entry
###end title 119
###begin p 120
###xml 417 425 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g001">Figure 1</xref>
###xml 305 308 <span type="species:ncbi:121791">NiV</span>
###xml 347 361 <span type="species:ncbi:10029">CHO cell lines</span>
(A) The percentage of ephrin cell surface expression (CSE) was measured by flow cytometry on CHO-pgs745 parental cells (CHO) and CHO-pgs745 cells stably expressing both full-length wild-type ephrins (B1, B2, and B3) and mutant ephrins (B1LW, B2YM, and B3YM); 10 mug/ml of EphB3-Fc (solid bar) and 1 nM of NiV-G-Fc (open bar) were used to bind the CHO cell lines, and the amount of binding was detected the same as in Figure 1B. The data are an average of triplicates +/- standard deviation (SD).
###end p 120
###begin p 121
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 168 176 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020007-g002">Figure 2</xref>
###xml 421 422 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 438 439 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 13 27 <span type="species:ncbi:10029">CHO cell lines</span>
###xml 103 106 <span type="species:ncbi:121791">NiV</span>
###xml 107 110 <span type="species:ncbi:11276">VSV</span>
(B) The same CHO cell lines used above were seeded at 105 cells per well and infected with pseudotyped NiV-VSV-DeltaG-Luc virus. The amount of entry was detected as in Figure 2A. One representative experiment of three is shown, and data are an average of triplicates +/- SD. In three independent experiments, the viral entry into B2YM cells was reduced by 45%, 68%, and 85%, respectively, compared to wild-type B2 cells (p < 0.03, paired t-test).
###end p 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. OAN and BL conceived and designed the experiments. OAN, MCW, SE, WW, and SVS performed the experiments and analyzed the data. OAN, HCA, EM, ABC, and RF contributed reagents/materials/analysis tools. OAN and BL wrote the paper.
###end p 122
###begin p 123
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by National Institutes of Health (NIH) grants (AI059051 and AI060694) to BL; NIH National Research Service Award grant to OAN (GM07185); a Microbial Pathogenesis Training grant (AI07323) to MCW; and an emerging infectious disease grant to ABC. We also acknowledge support to the University of California Los Angeles flow cytometry core funded through NIH grants (CA16042 and AI28697).
###end p 123
###begin p 124
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 163 174 <span type="species:ncbi:121791">Nipah virus</span>
Citation: Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, et al. (2006) Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2(2): e7.
###end p 125

